Major Shareholders

Summary of Issued Securities 

Ordinary Shares

 
Issued shares at 30 September 2020 396,605,348
Employee options over ordinary shares at 30 June 2020

18,867,400

Major Shareholders 
The top 20 shareholders in Pharmaxis Ltd on 30 September 2020 are:

Name

Number Of Shares

'000

% Total 
1. Citicorp Nominees Pty Limited 99,205 25%
2. Arix Bioscience Holdings Limited 43,693 11%
3. HSBC Custody Nominees (Australia) Limited 24,523 6%
4. National Nominees Limited 17,128 4%
5. JP Morgan Nominees Australia Limited 8,288 2%
6. Moggs Creek Pty Ltd (Moggs Creek Super A/C) 7,098 2%
7.  Dr Toby David Cohen 4,016 1%
8. BNP Paribas Nominees Pty Ltd (BNPP NYB Clearing Acc DRP)  2,658 1%
9. BNP Paribas Nominees Pty Ltd (IB AU Noms Retail Client DRP) 2,371 1%
10. Healthcare Management Consulting (Australia) Pty Ltd 2,220 1%
11. Pakasoluto Pty Limited (Barkl Family Super Fund) 2,036 1%
12. Joseph Wallace Carson 2,000 1%
13. Alpha Matilda Trdaing Pty Ltd (Alpha Matlda Superfund A/C) 1,878 0%
14. Ms Beu Xu + Mr Dongning Wu 1,875 0%
15. Mr Warren Patrick Hackett (Warren Hackett S/F A/C) 1,755 0%
16. George Engineering Pty Ltd (PG Super Fund) 1,750 0%
17. Simgon Pty Ltd (RK Super A/C) 1,750 0%
18. Blair House Pty Ltd (Robert Stork SF A/C) 1,600 0%
19. Mr Marco Andrea Negro 1,600 0%
20. DR Newnham Super Pty Ltd 1,527 0%

Note: the above tables are updated after each quarter end

Substantial Shareholders 

Name Percent Date 
BVF Partners LP 21% 30 May 2019
Arix Bioscience Holdings Limited 9% 22 October 2020
D&A Income Limited 7% 28 February 2019

Directors' Interests

Current director's interest notices can be found here: